SCHEMBL6036636

SCHEMBL6036636

C=CC(=O)NC(COC(C)=O)(COC(C)=O)COC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 4/20 0.37
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
THRB P10828 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.32
ZDHHC2 Q9UIJ5 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22215979 0.85 TSHR (0.39) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL21711136 0.84 ALDH1A1 (0.52) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL15222109 0.82 ALDH1A1 (0.39) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL22215981 0.78 THRB (0.38) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL4927446 0.77 ALDH1A1 (0.39) ALDH1A1TSHRLMNAHSD17B10SMN1; SMN2
SCHEMBL16627113 0.76 ALDH1A1 (0.42) ALDH1A1TSHRLMNAHSD17B10SMN1; SMN2
SCHEMBL14366076 0.76 ALDH1A1 (0.56) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL11922533 0.74 ALDH1A1 (0.33) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL11922535 0.74 ALDH1A1 (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL8766001 0.74 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246353-B1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS CENTRE NAT RECH SCIENT (FR) 2021-03-17 EP disclosed
US-10752976-B2 Process of extraction of a platinum group metal or gold from organic compositions with surfactants UNIVERSITE DE STRASBOURG (FR) 2020-08-25 US disclosed
US-20190316223-A1 Use of Surfactants to Extract a Platinum Group Metal or Gold from Organic Compositions CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2019-10-17 US disclosed
WO-2017198846-A1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-11-23 WO disclosed
EP-3246353-A1 USE OF SURFACTANTS TO EXTRACT A PLATINUM GROUP METAL OR GOLD FROM ORGANIC COMPOSITIONS Centre National De La Recherche Scientifique (FR) 2017-11-22 EP disclosed
US-20070275046-A1 Noval Surfactants and Applications Thereof TS PHARMA (FR) 2007-11-29 US disclosed
EP-1708993-A2 NOVEL SURFACTANTS AND APPLICATIONS THEREOF TS Pharma (FR) 2006-10-11 EP disclosed
WO-2005040105-A2 NOVEL SURFACTANTS AND APPLICATIONS THEREOF TS PHARMA (FR) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275046-A1 Noval Surfactants and Applications Thereof SGMS1, SGMS2, ANXA6 ALDH1A1 3574/4885CYP3A4 4655/4885CYP2C9 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.